Submission of Certificate under Reg. 74(5) of SEBI (DP) for 31.12.2024
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech has submitted to BSE a certificate from its Registrar and Share Transfer Agent (XL Softech Systems Ltd) under SEBI Regulation 74(5) for the quarter ended 31 December 2024. This is a routine compliance filing confirming that shares sent for dematerialisation during the quarter were properly verified, listed, and that physical certificates received were cancelled and the depository name substituted in the register of members within 30 days. The letter is signed by an Insolvency Professional (Namrata Randeri), and the correspondence email is a CIRP-specific address, indicating the company continues to be under the Corporate Insolvency Resolution Process. The filing is over a year late relative to the quarter it covers.
This is a routine procedural compliance submission and has no direct impact on stock price or shareholder value. The continued presence of an Insolvency Professional on record reinforces that the company remains under IBC resolution, which remains the key concern for investors.